Updates are available Correction dated 2019-10-30
Click to view Correction: https://doi.org/10.1186/s12915-019-0707-8
-
Authors
Shen, Yi
Dana, Hod
Abdelfattah, Ahmed S.
Patel, Ronak
Shea, Jamien
Molina, Rosana S.
Rawal, Bijal
Rancic, Vladimir
Chang, Yu-Fen
Wu, Lanshi
Chen, Yingche
Qian, Yong
Wiens, Matthew D.
Hambleton, Nathan
Ballanyi, Klaus
Hughes, Thomas E.
Drobizhev, Mikhail
Kim, Douglas S.
Koyama, Minoru
Schreiter, Eric R.
Campbell, Robert E. http://orcid.org/0000-0003-0604-092X
-
Funding
Funding for this research was provided by:
Alberta Innovates
Alberta Innovates - Health Solutions
Natural Sciences and Engineering Research Council of Canada (RGPIN-2014-06484, RGPIN 288338-2010)
University Hospital Foundation
Canadian Institutes of Health Research (MOP-123514)
Brain Canada
National Institutes of Health (U01 NS094246, UO1 NS090565)
- License Information
-
More Information
Article History
Received: 29 November 2017
Accepted: 3 January 2018
First Online: 16 January 2018
Change Date: 30 October 2019
Change Type: Correction
Change Details: In the online version of the article [ExternalRef removed], Figure S1 was mistakenly replaced with Figure 1.
Ethics approval
: All procedures for organotypic slices were carried out in compliance with the guidelines of the Canadian Council for Animal Care and with the approval of the University of Alberta Health Animal Care and Use Committee for Health Sciences. All experimental protocols for mouse and zebrafish in vivo imaging were conducted according to National Institutes of Health guidelines for animal research and were approved by the Institutional Animal Care and Use Committee at Janelia Research Campus (protocol 13-95).
: YFC is the founder of a company that will commercialize K-GECO1 as reported in this work. The other authors have declared that no competing interests exist.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
